ClinicalTrials.gg
CompletedNCT05480618SCOGAUpdated May 29, 2026Results posted

Slow Yogic-Derived Breathing and Respiration and Cardiovascular Variability in Spinal Cord Injury Patients

An interventional study of Slow Breathing in Spinal Cord Injuries and Slow Breathing, sponsored by Spaulding Rehabilitation Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by Spaulding Rehabilitation Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This research will aid in understanding of slow-breathing and its effect on heart rate and blood pressure in people with a spinal cord injury (SCI). This research will investigate if traditional 'yogic' breathing exercises can be performed by subjects with SCI and its influence on the cardiovascular system.

Read the detailed description

The relationship between respiratory patterns and cardiovascular variability in healthy persons has been previously studied. However, the impact of SCI on the interrelationships between the respiratory and cardiovascular systems remains relatively unstudied. The loss of autonomic control in SCI may mean that slow breathing has profound effects on cardiovascular variability. Hence, those with SCI may represent a population that could benefit from the potential physiologic effects of numerous yogic-based breathing patterns that can be applied anywhere any time. Hence, it is important to determine if slower breathing patterns can shift the cardiovascular control pattern to-wards important healthful effects. This physiological study will compare the effects of uncontrolled breathing and traditional yogic slow-breathing practices on cardiovascular variability in SCI patients.

02

Conditions studied

  • Spinal Cord Injuries
  • Slow Breathing

Keywords

  • resonance
  • yogic
  • pranayama
  • spinal cord injury
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's enrollment of 17 is below the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Spaulding Rehabilitation Hospital is the lead sponsor of 117 studies on the registry; 27 are open to participants now.

Of its 20 completed or terminated interventional studies of FDA-regulated products, 17 (85%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: 18-60 years old
  2. Wheelchair user
  3. Medically stable \& able to follow directions
  4. (18.5 - 35 kg/m2)

Exclusion criteria

Exclusion Criteria:

  1. BP >140/90 mmHg
  2. Current use of cardioactive medications (except medication to support blood pressure)
  3. Current tobacco use
  4. Significant arrhythmia
  5. Coronary artery disease
  6. Diabetes
  7. Renal Disease
  8. Cancer
  9. Epilepsy or other neurological diseases
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    Spinal Cord Injured Participants

    17 medically stable male and female subjects between 18 and 60 years old, BMI between 18.5-35 kg/m2, with a SCI and who use a wheelchair were recruited. Participants that did not speak English or with a history of renal, neurological, or coronary artery disease, cancer, diabetes, significant arrhythmia smoking, or using cardioactive medications were excluded.

    Behavioral: Slow Breathing

Interventions

  • BehavioralSlow Breathing

    On two separate visits (on Day 1 and between Day 7 and 9 of their self-practice) the subject will be coached on yoga breathing techniques. The breathing techniques will be varied in: 1. frequency (between 0.25 and 0.1 Hz) 2. Inspiratory:Expiratory (I:E) ratio or 'Duty Cycle' 3. with and without ujjayi (yogic throat restriction) 4. with and without inspiratory/expiratory breath holding At the end of the first coaching visit the subject will be given a diary to record their own practice of the breathing techniques they were coached on.

    Also known as: Yogic-Derived Breathing

06

What researchers measure

Primary outcomes

  1. HRV

    Heart rate variability assessed in the frequency domain during paced or unpaced breathing via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.

    Time frame: 7 minutes of paced or unpaced breathing at single study visit on Day 14

  2. BPV

    Systolic blood pressure variability from a Finometer assessed in the frequency domain via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.

    Time frame: 7 minutes of paced or unpaced breathing at single study visit on Day 14

  3. SpO2

    Peripheral oxygen saturation during paced or unpaced breathing

    Time frame: 7 minutes of paced or unpaced breathing at single study visit on Day 14

  4. Expired Carbon Dioxide (CO2)

    Expired CO2 from a nasal cannula

    Time frame: 7 minutes of paced or unpaced breathing at single study visit on Day 14

07

Results

Posted Apr 28, 2026
Limitations and caveats
This exploratory study had a limited sample size, consisting of only 12 participants and specific exclusion criteria, certain medical histories, smoking, and use of cardioactive medications potentially which may restrict the generalizability of the results. The recruitment strategy from a single rehabilitation hospital program may introduce selection bias, limiting the diversity of the sample and potentially impacting the external validity of the findings.

Participant flow

All participants had a spinal cord injury and were wheelchair users. After screening and signing an informed consent, participants receive instruction on how to perform the different breathing patterns (milestones/rows). After 2 instructional sessions and 2 weeks of practice on their own a study visit was scheduled. Participants completed all breathing patterns in a random order in a single study visit.

Breathing Familiarization (2 weeks)
Participant flow — Breathing Familiarization (2 weeks)
MilestoneSpinal Cord Injury
Started17
Completed12
Not completed5
Study Visit
Participant flow — Study Visit
MilestoneSpinal Cord Injury
Started12
Unpaced breathing12
0.25 hz breathing12
0.083 hz breathing12
Box breathing12
Extended exhale breathing12
Ujjayi breathing12
Completed12
Not completed0

Outcome measures

PrimaryHRV

Heart rate variability assessed in the frequency domain during paced or unpaced breathing via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.

Time frame:
7 minutes of paced or unpaced breathing at single study visit on Day 14
Reported as:
Mean · ms^2
HRV
ms^2Unpaced Breathing0.25 Hz Breathing0.083 Hz BreathingBox BreathingExtended Exhale BreathingUjjayi Breathing
Low Frequency R-R Interval Power (0.04-15 Hz)1421 ± 412813 ± 3073173 ± 9132819 ± 6814008 ± 9695490 ± 1465
High Frequency R-R Interval Power(0.15-40 Hz)756 ± 247802 ± 304477 ± 203722 ± 234897 ± 378759 ± 468
Total R-R interval Power (0.04 - 0.40 Hz)2177 ± 6371615 ± 4963650 ± 10423590 ± 8484905 ± 11596249 ± 1854
PrimaryBPV

Systolic blood pressure variability from a Finometer assessed in the frequency domain via Welch's modified periodogram method. Average power calculated by integrating the power spectral density in the low and high frequency bands.

Time frame:
7 minutes of paced or unpaced breathing at single study visit on Day 14
Reported as:
Mean · mmHg^2
BPV
mmHg^2Unpaced Breathing0.25 Hz Breathing0.083 Hz BreathingBox BreathingExtended Exhale BreathingUjjayi Breathing
Low Frequency Systolic Blood Pressure Power (0.04 - 1.5 Hz)2.6 ± 0.71.4 ± 0.56.1 ± 1.87.6 ± 1.76.9 ± 1.415.1 ± 4.0
High Frequency Systolic Blood Pressure Power(0.15 - 0.40 Hz)1.2 ± 0.21.5 ± 0.40.7 ± 0.22.5 ± 0.50.9 ± 0.21.7 ± 0.7
Total Systolic Blood Pressure Power(0.04 - 0.40 Hz)3.8 ± 0.82.8 ± 0.76.8 ± 1.810.2 ± 1.77.8 ± 1.416.8 ± 4
PrimarySpO2

Peripheral oxygen saturation during paced or unpaced breathing

Time frame:
7 minutes of paced or unpaced breathing at single study visit on Day 14
Reported as:
Mean · % O2 satuation
SpO2
% O2 satuationUnpaced Breathing0.25 Hz Breathing0.083 Hz BreathingBox BreathingExtended Exhale BreathingUjjayi Breathing
SpO296.1 ± 0.696.9 ± 0.597.2 ± 0.396.6 ± 0.596.7 ± 0.497.6 ± 0.3
PrimaryExpired Carbon Dioxide (CO2)

Expired CO2 from a nasal cannula

Time frame:
7 minutes of paced or unpaced breathing at single study visit on Day 14
Reported as:
Mean · mmHg
Expired Carbon Dioxide (CO2)
mmHgUnpaced Breathing0.25 Hz Breathing0.083 Hz BreathingBox BreathingExtended Exhale BreathingUjjayi Breathing
Expired Carbon Dioxide (CO2)35 ± 131 ± 136 ± 137 ± 136 ± 132 ± 2

Adverse events

Collected over From enrollment until end of study visit, up to 2 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Spinal Cord Injury0/17 (0%)0/17 (0%)0/17 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Spinal Cord Injury
Mean33.25 ± 5.97
Sex: Female, Male
Sex: Female, Male(Participants)Spinal Cord Injury
Female3
Male9
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Spinal Cord Injury
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American4
White8
More than one race0
Unknown or Not Reported0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Spinal Cord Injury
Hispanic or Latino1
Not Hispanic or Latino11
Unknown or Not Reported0
Body Mass Index
Body Mass Index(kg/m^2)Spinal Cord Injury
Mean26.2 ± 4.9
08

Study locations

1 site
  • Spaulding Rehabilitation Hospital
    Cambridge, Massachusetts 02138, United States
09

References and documents

Publications

  • Mazur MD, Hamner JW, Anand AN, Taylor JA. Cardiorespiratory Effects of Yogic Versus Slow Breathing in Individuals with a Spinal Cord Injury: An Exploratory Cohort Study. J Integr Complement Med. 2024 Sep;30(9):878-885. doi: 10.1089/jicm.2023.0641. Epub 2024 Mar 20. PubMed 38507692 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2022 to primary completion in Jan 2024, 16 months.

Results were first posted in Apr 2026, 2 years 3 months after primary completion.

Of 790 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's 16 months is below that.

Counting every sponsor, half of 839 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2022
First posted
Jul 29, 2022
StartActual
Aug 22, 2022
Primary completionActual
Jan 20, 2024
CompletionActual
Jan 20, 2024
Results first posted
Apr 28, 2026
Last update
May 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05480618
Responsible party
J. Andrew Taylor (Associate Professor of Physical Medicine and Rehabilitation, Principal Investigator, Spaulding Rehabilitation Hospital) — Principal investigator
First posted
Jul 29, 2022
Start date
Aug 22, 2022
Primary completion
Jan 20, 2024
Completion
Jan 20, 2024
Results posted
Apr 28, 2026
Last update
May 29, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion